Comparison of Extracorporeal Shock Wave to Different Muscle Targets in Post-Stroke Spasticity of Ankle Plantar Flexor
Stroke
About this trial
This is an interventional treatment trial for Stroke focused on measuring stroke, spasticity, shock wave, ankle
Eligibility Criteria
Inclusion Criteria: Subject with Cerebral stroke and age more 20 The degree of spasticity of plantar flexor is more than 1.( grading with the modified Ashworth scale) Stable vital sign Exclusion Criteria: Recurrent cerebral stroke, traumatic brain injury, brain tumor or other brain related disease. Other central nervous system diseases (SCI, Parkinson's disease), or other musculoskeletal disorders which affect the result of evaluating muscle spasticity. Malignant tumor, coagulation disorder, infection or use of pace which were not suitable for Extracorporeal Shock Wave. Received Extracorporeal Shock Wave or Botulinum injection for plantar flexor spasticity in recent 3 months. Subjects who was unable to complete Extracorporeal Shock Wave or evaluation due to impaired cognition or aphasia.
Sites / Locations
- National Taiwan University Hospital Hsin-Chu BranchRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
ESWT to gastrocnemius and soleus
ESWT to gastrocnemius
ESWT to gastrocnemius and soleus muscles (2000 shots for each muscle, a total of 4000 shots per session)
ESWT to gastrocnemius muscle (2000 shots per session)